Table 1: Demographic data, complications, comorbidity and ASA scores for non-frail and pre-frail/frail groups.

Variable Non-frail Group Pre-frail/Frail Group p-value CI Effect Size
Number, n (% of total) 49 (49%) 50 (51%) - - -
Male, n (% of the group) 31 (63%) 17 (34%) < 0.01* (-1.07) - (-0.24) -
Mean age, years (SD) 60.82 (7.81) 64.76 (9.17) 0.02* (-3.67) - (-0.27) 0.23
Mean stature, cm (SD) 173.18 (8.29) 167.36 (10.32) < 0.01* (1.04) - (4.78) 0.31
Mean body mass, kg (SD) 82.38 (16.83) 81.39 (19.35) 0.79 (-3.13) - (4.11) 0.03
Mean BMI, kg/m2 (SD) 27.49 (5.77) 28.99 (6.00) 0.21 (-1.92) - (0.43) 0.13
Adverse outcomes, n (SD) 0.72 (0.94) 1.51 (1.72) 0.01* (-0.69) - (-0.08) 0.30
Comorbidity Score, (0-35) (SD) 3.07 (2.05) 3.80 (2.37) 0.11 (-0.82) - (0.08) 0.17

p-value is adjusted with age; CI: confidence interval; SD: standard deviation; BMI: body mass index.